<DOC>
	<DOC>NCT00805415</DOC>
	<brief_summary>The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.</brief_summary>
	<brief_title>Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Healthy women willing to use nonhormonal methods of contraception Women with any contraindication for oral contraceptive use, for example but not limited to: presence or history of venous or arterial thrombotic / thrombembolic events, hypertension, presence or history of severe hepatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Oral Contraceptive</keyword>
	<keyword>Ovulation Inhibition</keyword>
</DOC>